Martha Morrell Biography and Net Worth

Insider of NeuroPace

Martha Morrell, M.D. has served as our Chief Medical Officer since 2004. Dr. Morrell has also served as a Clinical Professor of Neurology at Stanford University since 2004. Dr. Morrell previously served as the Caitlin Tynan Doyle Professor of Clinical Neurology at Columbia University and Director of the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital from 1998 to 2004. Prior to that, Dr. Morrell served on the faculty of the Stanford University School of Medicine and as the Director of the Stanford Comprehensive Epilepsy Center from 1990 to 1998. Dr. Morrell earned a B.A. from Barnard College and an M.D. from the Stanford University School of Medicine.

What is Martha Morrell's net worth?: The estimated net worth of Martha Morrell is at least $1.39 million as of February 21st, 2025. Morrell owns 81,993 shares of NeuroPace stock worth more than $1,391,421 as of December 5th. This net worth evaluation does not reflect any other investments that Morrell may own. Additionally, Morrell receives an annual salary of $728,680.00 as Insider at NeuroPace. Learn More about Martha Morrell's net worth.
How old is Martha Morrell?: Morrell is currently 67 years old. There are 3 older executives and no younger executives at NeuroPace. Learn More on Martha Morrell's age.
What is Martha Morrell's salary?: As the Insider of NeuroPace, Inc., Morrell earns $728,680.00 per year. The highest earning executive at NeuroPace is Mr. Joel D. Becker, CEO, President & Director, who commands a salary of $762,000.00 per year. Learn More on Martha Morrell's salary.
How do I contact Martha Morrell?: The corporate mailing address for Morrell and other NeuroPace executives is , , . NeuroPace can also be reached via phone at 650-237-2700 and via email at [email protected]. Learn More on Martha Morrell's contact information.
Has Martha Morrell been buying or selling shares of NeuroPace?: Martha Morrell has not been actively trading shares of NeuroPace during the last ninety days. Most recently, Martha Morrell sold 78,334 shares of the business's stock in a transaction on Friday, February 21st. The shares were sold at an average price of $13.72, for a transaction totalling $1,074,742.48. Following the completion of the sale, the insider now directly owns 81,993 shares of the company's stock, valued at $1,124,943.96. Learn More on Martha Morrell's trading history.
Who are NeuroPace's active insiders?: NeuroPace's insider roster includes Frank Fischer (Director), Martha Morrell (Insider), and Irina Ridley (General Counsel). Learn More on NeuroPace's active insiders.
Are insiders buying or selling shares of NeuroPace?: In the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,520,615 shares worth more than $53,335,173.08. The most recent insider tranaction occured on May, 14th when Major Shareholder Orbimed Advisors Llc sold 168,136 shares worth more than $2,664,955.60. Insiders at NeuroPace own 20.5% of the company. Learn More about insider trades at NeuroPace.
Information on this page was last updated on 5/14/2025.

Martha Morrell Insider Trading History at NeuroPace

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/21/2025	Sell	78,334	$13.72	$1,074,742.48	81,993
1/29/2025	Sell	100	$15.00	$1,500.00	86,962
1/24/2025	Sell	3,200	$15.01	$48,032.00	87,062
1/31/2024	Sell	1,923	$15.08	$28,998.84	96,014
1/24/2024	Sell	827	$15.03	$12,429.81	109,200
12/26/2023	Sell	102	$10.00	$1,020.00	123,327
12/20/2023	Sell	2,730	$10.14	$27,682.20	123,429
12/6/2023	Sell	11,005	$8.16	$89,800.80	126,159

Martha Morrell Buying and Selling Activity at NeuroPace

NeuroPace Company Overview

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Today's Range

Now: $16.97

$16.14

$17.09

50 Day Range

MA: $12.26

$9.40

$16.97

2 Week Range

Now: $16.97

$7.56

$18.98

Volume

223,137 shs

Average Volume

245,056 shs

Market Capitalization

$565.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Martha Morrell Biography and Net Worth

What is Martha Morrell's net worth?

How old is Martha Morrell?

What is Martha Morrell's salary?

How do I contact Martha Morrell?

Has Martha Morrell been buying or selling shares of NeuroPace?

Who are NeuroPace's active insiders?

Are insiders buying or selling shares of NeuroPace?